Workflow
munity Health Systems(CYH) - 2025 Q1 - Quarterly Report

Financial Performance - Net operating revenues increased from $3.140 billion for the three months ended March 31, 2024, to $3.159 billion for the same period in 2025, representing a growth of approximately 0.6%[110] - The company reported a net income of $25 million for the three months ended March 31, 2025, compared to a net loss of $(6) million for the same period in 2024[111] - Same-store net operating revenues increased by $94 million, or 3.1%, during the three months ended March 31, 2025, compared to the same period in 2024[134] - Net income was 0.8% of net operating revenues for the three months ended March 31, 2025, compared to a net loss of (0.2)% for the same period in 2024[142] - Operating expenses as a percentage of net operating revenues decreased from 92.6% in Q1 2024 to 91.0% in Q1 2025[135] Admissions and Services - Consolidated inpatient admissions decreased by 1.0% for the three months ended March 31, 2025, while same-store inpatient admissions increased by 4.0% during the same period[111] - Inpatient admissions decreased by 1.0% and adjusted admissions decreased by 2.3% during the three months ended March 31, 2025, compared to the same period in 2024[134] - Charity care services accounted for approximately 9.7% of net operating revenues for the three months ended March 31, 2025, compared to 10.1% for the same period in 2024[112] Cash Flow and Investments - Net cash provided by operating activities increased by $24 million to approximately $120 million for the three months ended March 31, 2025[144] - Net cash provided by investing activities was approximately $444 million for the three months ended March 31, 2025, compared to net cash used in investing activities of approximately $99 million for the same period in 2024[145] - Net cash used in financing activities was approximately $170 million for the three months ended March 31, 2025, a change of $183 million compared to net cash provided by financing activities of approximately $13 million for the same period in 2024[146] Debt and Financing - Approximately $29 million of the company's outstanding debt of approximately $11.3 billion is due within the next 12 months[153] - As of March 31, 2025, outstanding borrowings under the ABL Facility were $200 million, with approximately $651 million of additional borrowing capacity available[149] - The provision for income taxes increased to $42 million for the three months ended March 31, 2025, compared to $28 million for the same period in 2024[141] Divestitures and Acquisitions - The company divested two hospitals in Florida and sold a 50% ownership interest in a hospital in Mississippi, which represented annual net operating revenues of approximately $359 million in 2024, receiving total net proceeds of approximately $276 million[105] - The company completed the sale of Lake Norman Regional Medical Center for approximately $284 million on March 31, 2025[107] - The company has entered into definitive agreements to sell its 50% interest in Merit Health Madison and an 80% interest in Cedar Park Regional Medical Center for a total purchase price of $460 million, subject to adjustments[108] - The company is considering divesting additional hospitals and non-hospital businesses that are less complementary to its business strategy[109] Risks and Challenges - The company faces significant risks and uncertainties that may cause actual results to differ materially from forward-looking statements, including economic conditions, regulatory changes, and geopolitical instability[190] - The company is impacted by high interest rates and inflationary pressures, which could affect its financial performance and operational costs[190] - Changes in healthcare public policy and funding for Medicare and Medicaid programs could significantly affect the company's operations and revenue[190] - The company is experiencing challenges in hiring and retaining qualified medical personnel, leading to increased labor expenses due to competitive market conditions[192] - Ongoing economic conditions, including inflationary pressures and elevated interest rates, may negatively affect the company's liquidity in the future[154] Accounts Receivable and Collections - Patient accounts receivable from hospitals represent approximately 98% of total consolidated accounts receivable, with days revenue outstanding at 56 days as of March 31, 2025[170] - The company expects to collect less than 4% of the amounts being pursued by outside collection agencies, which totaled approximately $1.5 billion at March 31, 2025[168] - Total gross accounts receivable was approximately $17.5 billion as of March 31, 2025, compared to $17.3 billion as of December 31, 2024[171] - Insured receivables accounted for 73.3% of total gross accounts receivable as of March 31, 2025, up from 72.4% as of December 31, 2024[172] - The estimated implicit price concessions for self-pay accounts receivable were approximately 90% at both March 31, 2025, and December 31, 2024[172] Technology and Integration - The company is focused on integrating acquired hospitals and outpatient facilities to realize expected benefits, including growth in patient service revenues[192] - The company is exploring the development and adoption of emerging technologies, including artificial intelligence and machine learning, to enhance its services[192] Regulatory and Compliance - The company is subject to risks associated with cybersecurity threats and data privacy compliance, which could impact its operations[192] - The company is evaluating the impact of ASU 2023-09 on its consolidated financial statements, effective for annual periods beginning after December 15, 2024[187] Goodwill and Tax Positions - Goodwill recorded was approximately $3.8 billion as of March 31, 2025, with no impairment identified during the last evaluation[173] - The total amount of unrecognized tax benefits that would impact the effective tax rate, if recognized, was $43 million at March 31, 2025[185] - A total of $6 million of interest and penalties is included in the liability for uncertain tax positions at March 31, 2025[185]